curdlan has been researched along with Disease Models, Animal in 13 studies
D-hexose : A hexose that has D-configuration at position 5.
Disease Models, Animal: Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases.
Excerpt | Relevance | Reference |
---|---|---|
"In curdlan-treated SKG mice, arthritis, enthesitis, and ileitis were IL-23 dependent." | 3.80 | Interleukin-23 mediates the intestinal response to microbial β-1,3-glucan and the development of spondyloarthritis pathology in SKG mice. ( Baillet, AC; Benham, H; Brown, MA; Hasnain, SZ; Kikly, K; McGuckin, MA; Rehaume, LM; Ruutu, M; Strutton, G; Thomas, GP; Thomas, R; Tseng, HW; Velasco, J; Wang, R, 2014) |
"Stat-3p inhibition is a promising treatment for both inflammation and new bone formation in AS." | 1.62 | STAT3 phosphorylation inhibition for treating inflammation and new bone formation in ankylosing spondylitis. ( Choi, SH; Choi, YD; Jin, SH; Jo, S; Kim, J; Kim, JY; Kim, MJ; Kim, TH; Kim, TJ; Lee, YJ; Park, PR; Park, YS; Shim, SC; Song, HC; Won, EJ, 2021) |
"Curdlan was associated with production of the disease-resolving T-helper (Th) 1 and Th17-inducing cytokines interleukin (IL)-6, IL-1β, and IL-23, as well as with production of Th17 cytokines IL-17 and IL-22, as determined by enzyme-linked immunosorbent assay (ELISA) and real time polymerase chain reaction (RT-PCR)." | 1.39 | Successful therapy of visceral leishmaniasis with curdlan involves T-helper 17 cytokines. ( Das, PK; Ghosh, K; Kar, S; Saha, A; Sharma, G; Ukil, A, 2013) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 7 (53.85) | 24.3611 |
2020's | 6 (46.15) | 2.80 |
Authors | Studies |
---|---|
Xie, Z | 1 |
Yu, W | 1 |
Zheng, G | 1 |
Li, J | 1 |
Cen, S | 1 |
Ye, G | 1 |
Li, Z | 1 |
Liu, W | 1 |
Li, M | 1 |
Lin, J | 2 |
Su, Z | 1 |
Che, Y | 1 |
Ye, F | 1 |
Wang, P | 1 |
Wu, Y | 1 |
Shen, H | 1 |
Min, HK | 1 |
Choi, J | 1 |
Lee, SY | 1 |
Lee, AR | 1 |
Min, BM | 1 |
Cho, ML | 1 |
Park, SH | 1 |
Sato, F | 1 |
Nakamura, Y | 1 |
Katsuki, A | 1 |
Khadka, S | 1 |
Ahmad, I | 1 |
Omura, S | 1 |
Martinez, NE | 1 |
Tsunoda, I | 2 |
Ganbold, T | 1 |
Bao, Q | 1 |
Zandan, J | 1 |
Hasi, A | 1 |
Baigude, H | 1 |
Jo, S | 1 |
Won, EJ | 1 |
Kim, MJ | 1 |
Lee, YJ | 1 |
Jin, SH | 1 |
Park, PR | 1 |
Song, HC | 1 |
Kim, J | 1 |
Choi, YD | 1 |
Kim, JY | 1 |
Shim, SC | 1 |
Choi, SH | 1 |
Park, YS | 1 |
Kim, TH | 1 |
Kim, TJ | 1 |
Gu, C | 1 |
Upchurch, K | 1 |
Horton, J | 1 |
Wiest, M | 1 |
Zurawski, S | 1 |
Millard, M | 1 |
Kane, RR | 1 |
Joo, H | 1 |
Miller, LA | 1 |
Oh, S | 2 |
Benham, H | 1 |
Rehaume, LM | 1 |
Hasnain, SZ | 1 |
Velasco, J | 1 |
Baillet, AC | 1 |
Ruutu, M | 1 |
Kikly, K | 1 |
Wang, R | 1 |
Tseng, HW | 1 |
Thomas, GP | 1 |
Brown, MA | 1 |
Strutton, G | 1 |
McGuckin, MA | 1 |
Thomas, R | 1 |
Wu, TC | 1 |
Xu, K | 1 |
Banchereau, R | 1 |
Marches, F | 1 |
Yu, CI | 1 |
Martinek, J | 1 |
Anguiano, E | 1 |
Pedroza-Gonzalez, A | 1 |
Snipes, GJ | 1 |
O'Shaughnessy, J | 1 |
Nishimura, S | 1 |
Liu, YJ | 1 |
Pascual, V | 1 |
Banchereau, J | 1 |
Palucka, K | 1 |
Lee, EJ | 1 |
Vance, EE | 1 |
Brown, BR | 1 |
Snow, PS | 1 |
Clowers, JS | 2 |
Sakaguchi, S | 1 |
Rosenzweig, HL | 2 |
Jiang, N | 1 |
Zhao, G | 1 |
Hu, L | 1 |
Che, C | 1 |
Li, C | 1 |
Wang, Q | 1 |
Xu, Q | 1 |
Peng, X | 1 |
Nunez, G | 1 |
Rosenbaum, JT | 1 |
Davey, MP | 1 |
Libbey, JE | 1 |
Fujinami, RS | 1 |
Ghosh, K | 1 |
Sharma, G | 1 |
Saha, A | 1 |
Kar, S | 1 |
Das, PK | 1 |
Ukil, A | 1 |
13 other studies available for curdlan and Disease Models, Animal
Article | Year |
---|---|
TNF-α-mediated m
Topics: Adaptor Proteins, Signal Transducing; Adenosine; Animals; beta-Glucans; Biopsy; Bone Marrow; Case-Co | 2021 |
Vitronectin-derived bioactive peptide prevents spondyloarthritis by modulating Th17/Treg imbalance in mice with curdlan-induced spondyloarthritis.
Topics: Animals; beta-Glucans; Celecoxib; Cytokines; Disease Models, Animal; Disease Progression; Female; Ge | 2022 |
Curdlan, a Microbial β-Glucan, Has Contrasting Effects on Autoimmune and Viral Models of Multiple Sclerosis.
Topics: Animals; beta-Glucans; Disease Models, Animal; Mice; Multiple Sclerosis; Theilovirus | 2022 |
Modulation of Microglia Polarization through Silencing of NF-κB p65 by Functionalized Curdlan Nanoparticle-Mediated RNAi.
Topics: Animals; beta-Glucans; Cell Physiological Phenomena; Cells, Cultured; Disease Models, Animal; Drug D | 2020 |
STAT3 phosphorylation inhibition for treating inflammation and new bone formation in ankylosing spondylitis.
Topics: Adult; Animals; beta-Glucans; Cell Differentiation; Disease Models, Animal; Female; Humans; Ileitis; | 2021 |
Dectin-1 Controls TSLP-Induced Th2 Response by Regulating STAT3, STAT6, and p50-RelB Activities in Dendritic Cells.
Topics: Adult; Allergens; Animals; Antigens, Dermatophagoides; Antigens, Plant; beta-Glucans; Case-Control S | 2021 |
Interleukin-23 mediates the intestinal response to microbial β-1,3-glucan and the development of spondyloarthritis pathology in SKG mice.
Topics: Animals; Antibodies; beta-Glucans; Disease Models, Animal; Endoplasmic Reticulum Stress; Female; Ile | 2014 |
Reprogramming tumor-infiltrating dendritic cells for CD103+ CD8+ mucosal T-cell differentiation and breast cancer rejection.
Topics: Animals; beta-Glucans; Breast Neoplasms; CD8-Positive T-Lymphocytes; Cell Differentiation; Cell Line | 2014 |
Investigation of the relationship between the onset of arthritis and uveitis in genetically predisposed SKG mice.
Topics: Animals; Arthritis, Experimental; Arthritis, Rheumatoid; beta-Glucans; Disease Models, Animal; Disea | 2015 |
Indoleamine 2,3-Dioxygenase Is Involved in the Inflammation Response of Corneal Epithelial Cells to Aspergillus fumigatus Infections.
Topics: Animals; Aspergillus fumigatus; beta-Glucans; Cytokines; Disease Models, Animal; Epithelium, Corneal | 2015 |
Dectin-1 and NOD2 mediate cathepsin activation in zymosan-induced arthritis in mice.
Topics: Animals; Arthritis, Experimental; beta-Glucans; Cathepsins; Disease Models, Animal; Immunity, Innate | 2011 |
Possible role of interleukin-17 in a prime/challenge model of multiple sclerosis.
Topics: Adjuvants, Immunologic; Animals; beta-Glucans; Brain; Disease Models, Animal; Female; Genetic Vector | 2012 |
Successful therapy of visceral leishmaniasis with curdlan involves T-helper 17 cytokines.
Topics: Animals; Antibodies, Monoclonal; beta-Glucans; Disease Models, Animal; Immunologic Factors; Interfer | 2013 |